Tables
Tables for displaying information and data, with no column limit.
When the table contains several columns that exceed the page layout, slider arrows will automatically be displayed, to move between the columns to the right.
In adittion, the first column of the table can be frozen.
On the mobile device, since it is narrow screen - the slider arrows will always be displayed.
Colors - The table title color can be green/ Blue / Teal/ No color for title.
| Date | Topic | Details |
|---|---|---|
| October 01 | Good health and well-being | Advancing good health and well-being is core to our business and our mission to improve the lives of patients. |
| November 12 | Decent work and economic growth | We contribute to economic growth in the markets where we operate. We promote diversity, inclusion, gender equality, health and safety to create work environments where our employees can thrive. |
| December 03 | Industry, innvonation and infrastrusucture | We continuously innovate to uncover novel medicines and use the latest technologies and techniques to transform insights into treatments. |
| Date | Topic | Details |
|---|---|---|
| October 01 | Good health and well-being | Advancing good health and well-being is core to our business and our mission to improve the lives of patients. |
| November 12 | Decent work and economic growth | We contribute to economic growth in the markets where we operate. We promote diversity, inclusion, gender equality, health and safety to create work environments where our employees can thrive. |
| December 03 | Industry, innvonation and infrastrusucture | We continuously innovate to uncover novel medicines and use the latest technologies and techniques to transform insights into treatments. |
| Date | Topic | Details |
|---|---|---|
| October 01 | Good health and well-being | Advancing good health and well-being is core to our business and our mission to improve the lives of patients. |
| November 12 | Decent work and economic growth | We contribute to economic growth in the markets where we operate. We promote diversity, inclusion, gender equality, health and safety to create work environments where our employees can thrive. |
| December 03 | Industry, innvonation and infrastrusucture | We continuously innovate to uncover novel medicines and use the latest technologies and techniques to transform insights into treatments. |
| Date | Topic | Details |
|---|---|---|
| October 01 | Good health and well-being | Advancing good health and well-being is core to our business and our mission to improve the lives of patients. |
| November 12 | Decent work and economic growth | We contribute to economic growth in the markets where we operate. We promote diversity, inclusion, gender equality, health and safety to create work environments where our employees can thrive. |
| December 03 | Industry, innvonation and infrastrusucture | We continuously innovate to uncover novel medicines and use the latest technologies and techniques to transform insights into treatments. |
| Product name | Therapeutic Area | Strength | Product type | Active Ingredient | Size | Code | Launch date | Description | Number |
|---|---|---|---|---|---|---|---|---|---|
| Acebutolol | Antianginal Agent | 100 mg | Tablet | Zinc Oxide | Bottle 100 | 00093-7370-01 | December 03 | For the treatment of type 2 diabetes | 01933345 |
|
Allernix |
Antihistaminic | 400 mg | Caplet | Fentanyl Citrate | 24 100 | 00093-7370-01 | April 03 | For the treatment of type 2 diabetes | 01933346 |
|
Ampicillin Sodium Injection |
Antibiotic | 1000 mg | Powder for injection | ampicillin sodium | Vial 10 | 00093-7370-01 | December 03 | For the treatment of type 2 diabetes | 01933347 |
| Product name | Therapeutic Area | Strength | Product type | Active Ingredient | Size | Code | Launch date | Description | Number |
|---|---|---|---|---|---|---|---|---|---|
| Acebutolol | Antianginal Agent | 100 mg | Tablet | Zinc Oxide | Bottle 100 | 00093-7370-01 | December 03 | For the treatment of type 2 diabetes | 01933345 |
|
Allernix |
Antihistaminic | 400 mg | Caplet | Fentanyl Citrate | 24 100 | 00093-7370-01 | April 03 | For the treatment of type 2 diabetes | 01933346 |
|
Ampicillin Sodium Injection |
Antibiotic | 1000 mg | Powder for injection | ampicillin sodium | Vial 10 | 00093-7370-01 | December 03 | For the treatment of type 2 diabetes | 01933347 |
| Product name | Therapeutic Area | Strength | Product type | Active Ingredient | Size | Code | Launch date | Description | Number |
|---|---|---|---|---|---|---|---|---|---|
| Acebutolol | Antianginal Agent | 100 mg | Tablet | Zinc Oxide | Bottle 100 | 00093-7370-01 | December 03 | For the treatment of type 2 diabetes | 01933345 |
|
Allernix |
Antihistaminic | 400 mg | Caplet | Fentanyl Citrate | 24 100 | 00093-7370-01 | April 03 | For the treatment of type 2 diabetes | 01933346 |
|
Ampicillin Sodium Injection |
Antibiotic | 1000 mg | Powder for injection | ampicillin sodium | Vial 10 | 00093-7370-01 | December 03 | For the treatment of type 2 diabetes | 01933347 |
| Product name | Therapeutic Area | Strength | Product type | Active Ingredient | Size | Code | Launch date | Description | Number |
|---|---|---|---|---|---|---|---|---|---|
| Acebutolol | Antianginal Agent | 100 mg | Tablet | Zinc Oxide | Bottle 100 | 00093-7370-01 | December 03 | For the treatment of type 2 diabetes | 01933345 |
|
Allernix |
Antihistaminic | 400 mg | Caplet | Fentanyl Citrate | 24 100 | 00093-7370-01 | April 03 | For the treatment of type 2 diabetes | 01933346 |
|
Ampicillin Sodium Injection |
Antibiotic | 1000 mg | Powder for injection | ampicillin sodium | Vial 10 | 00093-7370-01 | December 03 | For the treatment of type 2 diabetes | 01933347 |